All In Biotech

NDA 020889 · Schering Plough

Lotrimin Af

Clotrimazole · Topical

Last checked: Nov 20, 2026Latest source record: Jan 16, 2002 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1989

Oct 27, 1989

Approved uses

1

Original approval plus efficacy supplements

Registered trials

127

31 Phase 3, 11 recruiting

FAERS reports

1,437

659 serious, 86 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

No structured label for this application in openFDA. Older and discontinued products often have none.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Oct 27, 1989 Original approval
1 products under this application
  • LOTRIMIN AF · CLOTRIMAZOLE 1% · Lotion, Topical · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Clotrimazole" as an intervention, any sponsor and status, largest first.

All 127 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • vulvovaginal burning sensation242
  • drug ineffective180
  • vulvovaginal pain79
  • condition aggravated75
  • vulvovaginal pruritus73
  • off label use71
  • drug interaction58
  • vulvovaginal discomfort47
  • constipation46
  • abdominal pain43
  • vaginal haemorrhage42
  • hypersensitivity41

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
200411
200511
200618
20075
200828
200947
201031
201141
201294
201356
201432
201520
201650
201751
201844
201957
202098
2021114
2022140
202394
2024107
2025136
2026152

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 342 on PubMed

Sponsor: Merck & Co.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.